Biblio

Author Title Type [ Year

]

Filters: Author is Zou, Jizhong [Clear All Filters]

2023

Harper R, Yu Q, Liu Y, Yang D, Zou J, Beers J, Rasheed AA de Jesus, Goldbach-Mansky R, Boehm M, Chen G. Corrigendum to "Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene" [Stem Cell Res. 64 (2022) 102933]. Stem Cell Res. 2023;69:103059.

Hong J, Cheng Y-S, Yang S, Swaroop M, Xu M, Beers J, Zou J, Huang W, Marugan JJ, Cai X, et al. Corrigendum to "iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II" [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007]. Exp Cell Res. 2023;433(2):113808.

Li Y, Ding J, Araki D, Zou J, Larochelle A. Modulation of WNT, Activin/Nodal and MAPK Signaling Pathways Increases Arterial Hemogenic Endothelium and Hematopoietic Stem/Progenitor Cell Formation During Human iPSC Differentiation. Stem Cells. 2023.

Cheng Y-S, Xu M, Chen G, Beers J, Chen CZ, Liu C, Zou J, Zheng W. A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction. Curr Protoc. 2023;3(8):e866.

Tamaoki N, Siebert S, Maeda T, Ha N-H, Good ML, Huang Y, Vodnala SK, Haro-Mora JJ, Uchida N, Tisdale JF, et al. Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells. Cell Rep Methods. 2023;3(4):100460.

Owusu-Ansah K, Pavlinov I, Xu M, Beers J, Chen C, Zheng W, Zou J. Three induced pluripotent stem cell lines (TRNDi033-A, TRNDi034-A, TRNDi035-A) generated from lymphoblasts of three apparently healthy individuals. Stem Cell Res. 2023;71:103135.

2022

Wu K, Takanohashi A, Woidill S, Seylani A, Helman G, Dias P, Beers J, Lin Y, Simons C, Wolvetang E, et al. Generation of human induced pluripotential stem cells from individuals with complex heterozygous, isogenic corrected, and homozygous Bloc1s1 mutations. Stem Cell Res. 2022;64:102905.

Harper R, Yu Q, Liu Y, Yang D, Zou J, Beers J, Rasheed AA de Jesus, Goldbach-Mansky R, Boehm M, Chen G. Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene. Stem Cell Res. 2022;64:102933.

Mehta A, Yu Q, Liu Y, Yang D, Zou J, Beers J, Rasheed AA de Jesus, Rastegar AT, Goldbach-Mansky R, Boehm M, et al. Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene. Stem Cell Res. 2022;65:102974.

Hong J, Cheng Y-S, Yang S, Swaroop M, Xu M, Beers J, Zou J, Huang W, Marugan JJ, Cai X, et al. iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II. Exp Cell Res. 2022:113007.

Feng X, Cheng XTang, Zheng P, Li Y, Hakim J, Zhang SQ, Anderson SM, Linask K, Zou J, Sheng ZHang, et al. Ligand-free mitochondria-localized mutant AR-induced cytotoxicity in spinal bulbar muscular atrophy. Brain. 2022.

2020

Haro-Mora JJ, Uchida N, Demirci S, Wang Q, Zou J, Tisdale JF. Biallelic correction of sickle cell disease-derived iPSCs confirmed at the protein level through serum-free iPS-sac/erythroid differentiation. Stem Cells Transl Med. 2020.

Xu X, Pradhan M, Xu M, Cheng Y-S, Beers J, Linask KL, Lin Y, Zheng W, Zou J. Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D, TRNDi024-D and TRNDi025-A) generated from fibroblasts of four healthy individuals. Stem Cell Res. 2020;49:102011.

Chen G, Li Z, Liu Y, Chen D, Beers J, Cudrici C, Ferrante EA, Schwartzbeck R, Dmitrieva N, Yang D, et al. Generation of human induced pluripotent stem cells (NIHTVBi004-A, NIHTVBi005-A, NIHTVBi006-A, NIHTVBi007-A, NIHTVBi008-A) from 5 CADASIL patients with NOTCH3 mutation. Stem Cell Res. 2020;45:101821.

Nickolls AR, Lee MM, Espinoza DF, Szczot M, Lam RM, Wang Q, Beers J, Zou J, Nguyen MQ, Solinski HJ, et al. Transcriptional Programming of Human Mechanosensory Neuron Subtypes from Pluripotent Stem Cells. Cell Rep. 2020;30(3):932-946.e7.

2019

Baskfield A, Li R, Beers J, Zou J, Liu C, Zheng W. Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene. Stem Cell Res. 2019;37:101436.

Li R, Baskfield A, Beers J, Zou J, Liu C, Alméciga-Díaz CJ, Zheng W. Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene. Stem Cell Res. 2019;36:101408.

Hong J, Xu M, Li R, Cheng Y-S, Kouznetsova J, Beers J, Liu C, Zou J, Zheng W. Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene. Stem Cell Res. 2019;37:101451.

Patterson K, Beers J, Linask KL, Lin Y, Hassanzadeh S, Sack MN, Zou J. Generation of two induced pluripotent stem cell lines (NHLBIi001-A and NHLBIi001-B) from a healthy Caucasian female volunteer with normal cardiac function. Stem Cell Res. 2019;41:101627.

Patterson K, Linask KL, Beers J, Zou J. Generation of two tdTomato reporter induced pluripotent stem cell lines (NHLBIi003-A-1 and NHLBIi003-A-2) by AAVS1 safe harbor gene-editing. Stem Cell Res. 2019;42:101673.

Cheng Y-S, Li R, Baskfield A, Beers J, Zou J, Liu C, Zheng W. A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene. Stem Cell Res. 2019;37:101435.

Huang W, Xu M, Li R, Baskfield A, Kouznetsova J, Beers J, Zou J, Liu C, Zheng W. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene. Stem Cell Res. 2019;37:101427.

Yang S, Cheng Y-S, Li R, Pradhan M, Hong J, Beers J, Zou J, Liu C, Might M, Rodems S, et al. An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene. Stem Cell Res. 2019;39:101496.

Pages